<DOC>
	<DOCNO>NCT01264575</DOCNO>
	<brief_summary>This prospective randomize double-blind dose-response study aim investigate ED50 ED95 intrathecal bupivacaine without epinephrine 100 mcg total knee replacement arthroplasty .</brief_summary>
	<brief_title>ED50 ED95 Intrathecal Bupivacaine With Without Epinephrine Total Knee Replacement Arthroplasty</brief_title>
	<detailed_description>Patients undergoing total knee replacement arthroplasty randomly assign six bupivacaine dose group ( 6 , 7 , 8 , 9 , 10 , 11 mg ) . Combined spinal-epidural anesthesia would perform . The dose would consider successful epidural supplement require surgery . A probit analysis perform calculate ED50 ED95 intrathecal bupivacaine without epinephrine total knee replacement arthroplasty . After measurement , ED50 ED95 bupivacaine epinephrine would compare without epinephrine .</detailed_description>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>The patient ASA class I II schedule total knee replacement surgery Patients previous spine surgery , diabetic neuropathy , skin infection site injection , allergy bupivacaine common contraindication spinal anesthesia exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>spinal anesthesia</keyword>
	<keyword>intrathecal bupivacaine</keyword>
	<keyword>epinephrine</keyword>
	<keyword>ED50</keyword>
	<keyword>ED95</keyword>
</DOC>